Table 37.
Country | N | GEN | STR | CIP | NAL | ERY | TET |
---|---|---|---|---|---|---|---|
2016 | |||||||
Campylobacter jejuni | |||||||
Belgium | 370 | 1.1 | 2.2 | 56.5 | 55.7 | 2.4 | 46.5 |
Croatia | 17 | 5.9 | 0 | 82.4 | 76.5 | 0 | 17.6 |
Estoniaa | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Germany | 246 | 0 | 0.4 | 75.2 | 72.8 | 1.2 | 51.2 |
Luxembourg | 54 | 0 | 1.9 | 66.7 | 66.7 | 1.9 | 550.6 |
Portugala | 7 | 0 | 0 | 100 | 85.7 | 28.6 | 100 |
Total (6 MSs) | 695 | 0.7 | 1.4 | 64.9 | 63.3 | 2.2 | 48.6 |
Campylobacter coli | |||||||
Croatia | 12 | 0 | 25 | 66.7 | 66.7 | 0 | 25 |
Germany | 60 | 0 | 10 | 85 | 75 | 13.3 | 76.7 |
Luxembourg | 39 | 0 | 15.4 | 74.4 | 71.8 | 7.7 | 76.9 |
Portugal | 11 | 0 | 0 | 100 | 100 | 45.5 | 90.9 |
Total (4 MSs) | 122 | 0 | 12.3 | 81.1 | 75.4 | 13.1 | 73 |
2015 | |||||||
Campylobacter jejuni | |||||||
Austria | 67 | 0 | 3 | 73.1 | 71.6 | 0 | 43.3 |
Netherlands | 80 | 0 | 0 | 62.5 | 62.5 | 3.8 | 37.5 |
Portugala | 4 | 0 | 0 | 100 | 100 | 25 | 75 |
Total (3 MSs) | 151 | 0 | 1.3 | 68.2 | 67.5 | 2.6 | 41.1 |
Campylobacter coli | |||||||
Austria | 40 | 0 | 15 | 85 | 85 | 5 | 72.5 |
Netherlands | 12 | 0 | 8.3 | 91.7 | 100 | 8.3 | 75 |
Portugal | 15 | 6.7 | 33.3 | 100 | 100 | 40 | 100 |
Total (3 MSs) | 67 | 1.5 | 17.9 | 89.6 | 91 | 13.4 | 79.1 |
ECOFFs: epidemiological cut‐off values; MSs: Member States; N: number of isolates tested; % Res: percentage of resistant isolates per category of susceptibility; CIP: ciprofloxacin; ERY: erythromycin; GEN: gentamicin; NAL: nalidixic acid; STR: streptomycin; TET: tetracycline.
Occurrence of resistance assessed on less than 10 isolates.